142 related articles for article (PubMed ID: 11769601)
1. [Orthotopic liver transplantation: report of 70 cases].
Chen G; He X; Zhu X
Zhonghua Wai Ke Za Zhi; 2001 Sep; 39(9):679-83. PubMed ID: 11769601
[TBL] [Abstract][Full Text] [Related]
2. Liver transplantation at the Sun Yat-Sen University of Medical Sciences in China.
Huang J; He X; Chen G; Zhu X; Lu M; Wang G; Fu Y; Yang Y; Guan X
Chin Med J (Engl); 2002 Apr; 115(4):543-8. PubMed ID: 12133294
[TBL] [Abstract][Full Text] [Related]
3. Liver transplantation for patients with hepatitis B virus-related diseases.
Huang J; He X; Zhu X; Chen G
Zhonghua Wai Ke Za Zhi; 2001 Oct; 39(10):737-41. PubMed ID: 16201183
[TBL] [Abstract][Full Text] [Related]
4. [Liver transplantation for hepatocellular carcinoma: a report of 60 cases].
Chen GH; Yang Y; Lu MQ; Cai CJ; He XS; Zhu XF; Xu C; Li H; Huang JF
Zhonghua Wai Ke Za Zhi; 2004 Apr; 42(7):413-6. PubMed ID: 15144669
[TBL] [Abstract][Full Text] [Related]
5. [Orthotopic liver transplantation for end-stage liver diseases in 71 cases].
Zheng S; Huang D; Wang W; Liang T; Zhang M; Shen Y; Wu J; Xu X; Lu Aw AW; Liao Sy SY
Zhonghua Gan Zang Bing Za Zhi; 2002 Feb; 10(1):7-9. PubMed ID: 11856489
[TBL] [Abstract][Full Text] [Related]
6. Prevention and treatment of hepatitis B relapse after liver transplantation.
Zhu X; Lu M; Wang G; Cai C; Yang Y; He X; Chen G; Huang J
Chin Med J (Engl); 2001 Jan; 114(1):73-5. PubMed ID: 11779441
[TBL] [Abstract][Full Text] [Related]
7. Clinical impact and efficacy of lamivudine therapy in de novo hepatitis B infection after liver transplantation.
Castells L; Vargas V; Rodríguez F; Allende H; Buti M; Sánchez-Avila JF; Jardí R; Margarit C; Pumarola T; Esteban R; Guardia J
Liver Transpl; 2002 Oct; 8(10):892-900. PubMed ID: 12360430
[TBL] [Abstract][Full Text] [Related]
8. Association between hepatitis B and hepatocellular carcinoma recurrence in patients undergoing liver transplantation.
Kiyici M; Yilmaz M; Akyildiz M; Arikan C; Aydin U; Sigirli D; Nart D; Yilmaz F; Ozacar T; Karasu Z; Kilic M
Transplant Proc; 2008 Jun; 40(5):1511-7. PubMed ID: 18589140
[TBL] [Abstract][Full Text] [Related]
9. Hepatocellular carcinoma in children and effect of living-donor liver transplantation on outcome.
Arikan C; Kilic M; Nart D; Ozgenc F; Ozkan T; Tokat Y; Yagci RV; Aydogdu S
Pediatr Transplant; 2006 Feb; 10(1):42-7. PubMed ID: 16499586
[TBL] [Abstract][Full Text] [Related]
10. Liver transplantation for patients with hepatocellular carcinoma at the Liver Cancer Institute of Fudan University, China.
Zhou J; Fan J; Wu ZQ; Qiu SJ; Huang XW; Yu Y; Wang Z; Sun J; Xiao YS; He YF; Yang GH; Song K; Yuan Z; Wang YQ; Tang ZY
Chin Med J (Engl); 2005 Apr; 118(8):654-9. PubMed ID: 15899120
[TBL] [Abstract][Full Text] [Related]
11. Comparison of clinical outcomes in chronic hepatitis B liver transplant candidates with and without hepatocellular carcinoma.
Wong SN; Reddy KR; Keeffe EB; Han SH; Gaglio PJ; Perrillo RP; Tran TT; Pruett TL; Lok AS
Liver Transpl; 2007 Mar; 13(3):334-42. PubMed ID: 17154401
[TBL] [Abstract][Full Text] [Related]
12. [Lamivudine as prophylaxis against hepatitis B virus reinfection following orthotopic liver transplantation].
Zheng S; Wu J; Wang W; Huang D; Liang T; Lu A
Zhonghua Yi Xue Za Zhi; 2002 Apr; 82(7):445-8. PubMed ID: 12133511
[TBL] [Abstract][Full Text] [Related]
13. Predictors of survival after liver transplantation for hepatocellular carcinoma associated with Hepatitis C.
Shimoda M; Ghobrial RM; Carmody IC; Anselmo DM; Farmer DG; Yersiz H; Chen P; Dawson S; Durazo F; Han S; Goldstein LI; Saab S; Hiatt J; Busuttil RW
Liver Transpl; 2004 Dec; 10(12):1478-86. PubMed ID: 15558585
[TBL] [Abstract][Full Text] [Related]
14. High-titer antibody to hepatitis B surface antigen before liver transplantation can prevent de novo hepatitis B infection.
Su WJ; Ho MC; Ni YH; Chen HL; Hu RH; Wu YM; Chang MH; Lee PH
J Pediatr Gastroenterol Nutr; 2009 Feb; 48(2):203-8. PubMed ID: 19179883
[TBL] [Abstract][Full Text] [Related]
15. Role of long-term lamivudine treatment of hepatitis B virus recurrence after liver transplantation.
Woo HY; Choi JY; Jang JW; You CR; Bae SH; Yoon SK; Yang JM; Choi SW; Han NI; Kim DG
J Med Virol; 2008 Nov; 80(11):1891-9. PubMed ID: 18814257
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of lamivudine therapy for decompensated liver cirrhosis due to hepatitis B virus with or without hepatocellular carcinoma.
Hiraoka A; Michitaka K; Kumagi T; Kurose K; Uehara T; Hirooka M; Yamashita Y; Kubo Y; Miyaoka H; Iuchi H; Okada S; Ohmoto M; Yamamoto K; Horiike N; Onji M
Oncol Rep; 2005 Jun; 13(6):1159-63. PubMed ID: 15870937
[TBL] [Abstract][Full Text] [Related]
17. Outcome of liver transplantation for hepatitis B in the United States.
Kim WR; Poterucha JJ; Kremers WK; Ishitani MB; Dickson ER
Liver Transpl; 2004 Aug; 10(8):968-74. PubMed ID: 15390321
[TBL] [Abstract][Full Text] [Related]
18. Early mortality in Taiwanese lamivudine-treated patients with chronic hepatitis B-related decompensation: evaluation of the model for end-stage liver disease and index scoring systems as prognostic predictors.
Dai CY; Chuang WL; Hou NJ; Lee LP; Hsieh MY; Lin ZY; Chen SC; Huang JF; Hsieh MY; Wang LY; Tsai JF; Wen-Yu ; Yu ML
Clin Ther; 2006 Dec; 28(12):2081-92. PubMed ID: 17296464
[TBL] [Abstract][Full Text] [Related]
19. Factors associated with viral breakthrough in lamivudine monoprophylaxis of hepatitis B virus recurrence after liver transplantation.
Chan HL; Chui AK; Lau WY; Chan FK; Wong ML; Tse CH; Rao AR; Wong J; Sung JJ
J Med Virol; 2002 Oct; 68(2):182-7. PubMed ID: 12210406
[TBL] [Abstract][Full Text] [Related]
20. Orthotopic liver transplantation in patients with human immunodeficiency virus and end-stage liver disease.
Neff GW; Bonham A; Tzakis AG; Ragni M; Jayaweera D; Schiff ER; Shakil O; Fung JJ
Liver Transpl; 2003 Mar; 9(3):239-47. PubMed ID: 12619020
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
